U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06896409) titled 'PuraStat(R) Combined With Adrenaline Versus Standard of Care in Upper Gastrointestinal Bleeding' on Feb. 01.
Brief Summary: PuraStat(R) is a novel gel that offers several advantages over traditional hemostatic powders. Its transparency allows for continuous visualization of the bleeding site, and it can be applied in narrow spaces or in combination with other treatments. Additionally, the pre-filled syringe design ensures ease of handling and precise delivery.
Most published data on PuraStat(R) as a hemostatic agent originates from surgical settings. In endoscopy, its primary applications have been in polypectomy-related hemostasi...